Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Credit Suisse First Boston (informally CSFB) was the investment banking division of Credit Suisse Group, prior to 2006. It was active in investment banking, capital markets and financial services.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2000 | BrightLink Networks | Series C | 52M |
8/2000 | Advertising.com | Venture Round | 0 |
4/2000 | NetEffect Corp | Series B | 0 |
8/2000 | Advertising.com | Venture Round | 57M |
6/2002 | Aspen Insurance Holdings Limited | Private Equity Round | 0 |
6/2001 | Salesforce | Series D | 0 |
6/2000 | Highway To Health | Venture Round | 14.5M |
4/2000 | enCommerce Inc. | Series D | 0 |
12/2002 | Sunesis Pharmaceuticals | Series C | 6M |
1/2000 | ZLand.com | Private Equity Round | 20M |
1/2002 | Oblix | Venture Round | 0 |
3/2001 | Ishoni Networks | Series C | 0 |
9/2000 | Creditex | Series C | 10M |
1/2004 | PTC Therapeutics | Series E | 35M |
9/2000 | Novalux | Series C | 0 |
2/2000 | Allegis Corporation | Venture Round | 0 |
7/2000 | Amber Networks | Series C | 91M |
12/2000 | Oxagen | Venture Round | 0 |
6/2004 | PTC Therapeutics | Series E | 0 |
10/2006 | CELLFOR | Venture Round | 5.6M |
12/2001 | Sabeus Photonics | Series C | 16M |
7/2000 | eRoom Technology | Private Equity Round | 21M |
8/2000 | Prime Advantage | Series C | 0 |
2/2007 | PTC Therapeutics | Series F | 10M |
1/2001 | Network Elements | Series B | 77M |
4/2001 | LuxN | Series D | 0 |
6/2000 | LuxN | Series C | 0 |
7/2000 | Sunesis Pharmaceuticals | Series C | 60M |
9/2004 | Sunesis Pharmaceuticals | Series C | 14M |
6/2000 | LNG Holdings | Private Equity Round | 1.1B |
1/2001 | RightNow Technologies | Series B | 15M |
8/2000 | Oblix | Series E | 0 |
2/2001 | Looking Glass Networks | Debt Financing | 275M |
3/2001 | iolon, inc. | Series B | 53M |
11/1999 | Greenwich Technology Partners | Venture Round | 20M |
5/2000 | NetVendor | Series C | 52M |
3/2000 | Keystroke.com | Series B | 14M |
9/2000 | Allegis Corporation | Venture Round | 0 |
4/2000 | FusionOne | Venture Round | 50M |
3/2000 | eYada | Venture Round | 25M |
5/2000 | CapitalKey Advisors | Venture Round | - |
1/2001 | TrueSAN Networks | Series B | 0 |
8/2000 | PlusFunds.com | Venture Round | 0 |
7/2000 | Totality | Series B | 0 |
10/1999 | Click2learn | Post-IPO Equity | 10M |
6/2004 | Upstream Technologies | Venture Round | - |
4/2000 | TradingEdge | Venture Round | 52M |
2/2007 | PTC Therapeutics | Series F | 0 |
10/2006 | CELLFOR | Venture Round | 0 |
9/2004 | Sunesis Pharmaceuticals | Series C | 0 |
6/2004 | PTC Therapeutics | Series E | 0 |
6/2004 | Upstream Technologies | Venture Round | - |
1/2004 | PTC Therapeutics | Series E | 0 |
12/2002 | Sunesis Pharmaceuticals | Series C | 0 |
6/2002 | Aspen Insurance Holdings Limited | Private Equity Round | 0 |
1/2002 | Oblix | Venture Round | 0 |
12/2001 | Sabeus Photonics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|